National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access
Key finding:
KUALA LUMPUR, Malaysia, July 1, 2024 /PRNewswire/ — National Cancer Society Malaysia (NCSM) and Gene Solutions are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on expanding awareness and enabling access to multi-cancer early detection (MCED) testing for the Malaysian population. This landmark partnership was inked at the inaugural National Cancer Congress Malaysia 2024 and aims to revolutionize cancer detection and improve early diagnosis rates across the nation.Publisher:prnewswire.com
Publication date:01 July 2024
Reproductive health experts collaborate in multi-centre study with Gene Solutions to develop next-generation prenatal genetic screening test that predicts for adverse pregnancy complications
Key finding:
SINGAPORE, March 19, 2024 /PRNewswire/ — Gene Solutions announced a multi-centre research collaboration with leading OBGYN centres in Vietnam, Singapore, Indonesia, and Philippines on the early prediction of pregnancy complications. This clinical study involving >10,000 women would be the first of its kind, focusing on maternal health, enabling earlier prediction of potential pregnancy complications.Publisher:prnewswire.com
Publication date:19 March 2024
Gene Solutions raises $21m series B, targeting regional expansion
Key finding:
Gene Solutions, which bills itself as Vietnam’s largest genetic testing company, has raised US$21 million in a series B round from Mekong Capital. This follows a US$15 million investment that the private equity investor made in the company in 2021.Publisher:techinasia.com
Publication date:20 September 2023
Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia
Key finding:
HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ — In January 2023, Vietnam’s Medical Genetics Institute & Gene Solutions published their research paper on Cancer Investigation: Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim report from a Vietnamese longitudinal prospective cohort study of 2,795 participants.Publisher:prnewswire.com
Publication date:25 April 2023
